This facility was designed as a multi-product facility for the manufacture of bulk purified proteins and monoclonal antibodies for use as therapeutics and diagnostic tools. We have worked closely with regulatory authorities and consultants to ensure that the design of this facility meets cGMP standards. The facility design minimizes downtime and maximizes flexibility for both scheduling and alternative production technologies such as fed-batch and perfusion.